Author:
Telles João Paulo,Diegues Mariana Suelotto,Migotto Karen Cristina,de Souza Borges Olivia,Reghini Rodrigo,Gavazza Brenda Vianna,Pinto Leonardo,Caruso Pedro,e Silva Ivan Leonardo França,Schmidt Stephan,de Lima Moreira Fernanda
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference40 articles.
1. MacDougall C, Chambers H (2011) Aminogylcosides. In: Brunton L, Chamber B, Knollman B (eds) The pharmacological basis of therapeutics. Mc Graw Hill, New York, NY, USA, pp 1507–1517
2. Prayle A, Watson A, Fortnum H, Smyth A (2010) Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis. Thorax 65:654–658
3. Pitta RD, Gasparetto J, De Moraes TP, Telles JP, Tuon FF (2020) Antimicrobial therapy with aminoglycoside or meropenem in the intensive care unit for hospital associated infections and risk factors for acute kidney injury. Eur J Clin Microbiol Infect Dis 39(4):723–728
4. Soman R, Bakthavatchalam YD, Nadarajan A, Dwarakanathan HT, Venkatasubramanian R, Veeraraghavan B (2021) Is it time to move away from polymyxins?: evidence and alternatives. Eur J Clin Microbiol Infect Dis 40:461–475
5. Marsot A, Guilhaumou R, Riff C, Blin O (2017) Amikacin in critically Ill patients: A review of population pharmacokinetic studies. Clin Pharmacokinet 56:127–138